Cuong Do is the President and CEO of BioVie, a clinical-stage biopharmaceutical company focusing on drug therapies for liver disease.
Cuong Do is the President and CEO of BioVie, a clinical-stage biopharmaceutical company focusing on drug therapies for liver disease, neurodegenerative disorders, and certain cancers. He emphasizes in interviews BioVie's molecule Bezy, which has shown promise in slowing cognitive decline in Alzheimer's trials.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide